ACTL6A suppresses p21<sup>Cip1</sup> tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype.

Shrestha, Suruchi; Adhikary, Gautam; Naselsky, Warren; Xu, Wen; Friedberg, Joseph S; Eckert, Richard L

ACTL6A suppresses p21^Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype.

Shrestha, Suruchi; Adhikary, Gautam; Naselsky, Warren; Xu, Wen; Friedberg, Joseph S; Eckert, Richard L.

Afiliação

Shrestha S; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.
Adhikary G; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.
Naselsky W; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Xu W; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.
Friedberg JS; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Eckert RL; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.

Oncogenesis ; 10(10): 70, 2021 Oct 23.

Article em En | MEDLINE | ID: mdl-34689163

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article